MindBloom

Telehealth Companies Applaud DEA for Delaying Telemedicine Restrictions of Controlled Substances

The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back Covid-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities, a decision telehealth companies like Bicycle Health and Mindbloom are in support of.

By Marissa Plescia

With Mindbloom acquisition, Welltok ramps up mobile health gaming content

The interest in gaming technology as a way to help consumers make better health and wellness decisions has led Welltok to acquire Seattle-based gaming developer Mindbloom for an undisclosed amount. The digital health company, which works with insurers to provide content to guide and motivate their members to adopt healthy behaviors, will add Mindbloom’s mobile […]

By Stephanie Baum

Mayo Clinic Platform Program to Help Clinical Digital Health Startups Succeed

Mayo Clinic has developed a new tool that could speed up the time it takes for digital health companies to validate their tech to hospitals.

By Mayo Clinic Platform